Atlas Trials

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

Clinical trial NCT03609827 · COMPLETED

Trial details

NCT number
NCT03609827
Sponsor
University of California, San Francisco
Status
COMPLETED
Study type
OBSERVATIONAL
Hematologic MalignanciesNonmalignant DiseasesImmunodeficienciesHemoglobinopathiesGenetic Inborn Errors of MetabolismFanconi's AnemiaThalassemiaSickle Cell Disease
Start date
2015-09-01
Primary completion
2021-05-31
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.